News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,242 Results
Type
Article (39454)
Company Profile (250)
Press Release (654538)
Section
Business (204165)
Career Advice (2007)
Deals (35426)
Drug Delivery (93)
Drug Development (80969)
Employer Resources (169)
FDA (16147)
Job Trends (14836)
News (345070)
Policy (32490)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2541)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49354)
ALS (75)
Alzheimer's disease (1323)
Antibody-drug conjugate (ADC) (98)
Approvals (16132)
Artificial intelligence (211)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11638)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (178)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (232)
Cancer (1803)
Cardiovascular disease (133)
Career advice (1671)
Career pathing (28)
CAR-T (130)
Cell therapy (374)
Cervical cancer (13)
Clinical research (65410)
Collaboration (702)
Compensation (402)
Complete response letters (18)
COVID-19 (2570)
CRISPR (31)
C-suite (182)
Cystic fibrosis (97)
Data (1728)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (225)
Diagnostics (6322)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (106)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (66)
Earnings (85833)
Editorial (28)
Employer branding (21)
Employer resources (145)
Events (111271)
Executive appointments (593)
FDA (17128)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (631)
Gene editing (86)
Generative AI (18)
Gene therapy (255)
GLP-1 (661)
Government (4368)
Grass and pollen (4)
Guidances (46)
Healthcare (18793)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (91)
Indications (23)
Infectious disease (2689)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (71)
Interviews (311)
IPO (16482)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (9)
Labor market (27)
Layoffs (442)
Leadership (14)
Legal (7895)
Liver cancer (69)
Lung cancer (264)
Lymphoma (122)
Machine learning (2)
Management (57)
Manufacturing (248)
MASH (57)
Medical device (13289)
Medtech (13294)
Mergers & acquisitions (19354)
Metabolic disorders (583)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (70)
Neuropsychiatric disorders (23)
Neuroscience (1754)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2225)
Now hiring (36)
Obesity (320)
Opinion (196)
Ovarian cancer (61)
Pain (70)
Pancreatic cancer (69)
Parkinson's disease (119)
Partnered (17)
Patents (181)
Patient recruitment (82)
Peanut (45)
People (56944)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20370)
Phase II (28810)
Phase III (21453)
Pipeline (813)
Podcasts (40)
Policy (102)
Postmarket research (2563)
Preclinical (8593)
Press Release (64)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (242)
Rare diseases (339)
Real estate (5901)
Recruiting (64)
Regulatory (22011)
Reports (43)
Research institute (2315)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (1)
RSV (36)
Schizophrenia (59)
Series A (114)
Series B (68)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1906)
Special edition (13)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (12)
Supply chain (56)
The Weekly (25)
United States (19565)
Vaccines (627)
Venture capitalists (35)
Webinars (12)
Weight loss (216)
Women's health (30)
Worklife (13)
Date
Last 7 days (669)
Last 30 days (2632)
Last 365 days (33973)
2025 (5893)
2024 (35224)
2023 (40082)
2022 (51178)
2021 (55717)
2020 (54099)
2019 (46554)
2018 (35034)
2017 (32135)
2016 (31502)
2015 (37558)
2014 (31328)
2013 (26356)
2012 (28576)
2011 (29269)
2010 (27339)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (213)
Arkansas (12)
Asia (37583)
Australia (6145)
California (5070)
Canada (1771)
China (419)
Colorado (232)
Connecticut (240)
Delaware (111)
Europe (80769)
Florida (748)
Georgia (174)
Idaho (57)
Illinois (467)
India (21)
Indiana (275)
Iowa (7)
Japan (128)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (782)
Massachusetts (3853)
Michigan (203)
Minnesota (348)
Mississippi (2)
Missouri (72)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1442)
New Mexico (27)
New York (1451)
North Carolina (871)
North Dakota (7)
Northern California (2225)
Ohio (179)
Oklahoma (13)
Oregon (32)
Pennsylvania (1154)
Puerto Rico (6)
Rhode Island (24)
South America (1093)
South Carolina (15)
South Dakota (1)
Southern California (1906)
Tennessee (84)
Texas (751)
Utah (155)
Virginia (118)
Washington D.C. (55)
Washington State (484)
West Virginia (3)
Wisconsin (44)
694,242 Results for "qiagen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN delivers solid Q4 2024 growth ahead of outlook
February 5, 2025
·
7 min read
Press Releases
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
January 10, 2025
·
7 min read
Press Releases
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
February 14, 2025
·
5 min read
Press Releases
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
March 6, 2025
·
6 min read
Biotech Bay
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs
QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret, that brings significant performance and scalability enhancements tailored for high-throughput, next-generation sequencing labs moving to larger test panels and higher test volumes.
June 13, 2024
·
7 min read
Press Releases
QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase
January 13, 2025
·
6 min read
Pharm Country
QIAGEN announces 2028 strategy for solid profitable growth
QIAGEN will announce at its Capital Markets Day a commitment to deliver solid profitable growth through 2028 – led by about 7% compound annual sales growth at constant exchange rates during the four-year period and achieving at least a 31% CER adjusted operating income margin in 2028.
June 17, 2024
·
10 min read
BioCapital
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
QIAGEN announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis infection with modern blood-based tests such as QIAGEN’s market-leading QuantiFERON-TB Gold Plus.
June 27, 2024
·
7 min read
Press Releases
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million
January 16, 2025
·
7 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
January 15, 2025
·
1 min read
1 of 69,425
Next
